Tim Sakkers Wins Young Innovator Award 2026 | UtrechtInc Startup

We are proud to share that Tim Sakkers, founder of ReveltaDx and a participant in the UtrechtInc Science Validation Program, has won the Young Innovator Award 2026 at Innovation for Health. The award recognises promising innovations with strong potential to impact healthcare.

Building ReveltaDx
ReveltaDx focuses on improving the diagnosis of heart disease in women — an area where current diagnostic approaches often fall short. By addressing this gap, the startup aims to contribute to more accurate and timely diagnosis, supporting better healthcare outcomes.

The role of validation
Tim participated in the UtrechtInc Science Validation Program in 2025, where he worked on validating the core assumptions behind his idea.

This phase is essential for early-stage founders, helping them:

• Test their concept with real stakeholders
• Understand the problem space more deeply
• Refine their value proposition
• Build a foundation for further development

Winning the Young Innovator Award marks an important milestone in the journey of ReveltaDx. It highlights how early validation, combined with continued development, can lead to meaningful recognition and progress.